Clinical Trials

10 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

NCT01779050 2022-11-01

Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells

7 enrolled 8 charts

Breast Neoplasms

NCT01929811 2022-04-06

NeoMET

92 enrolled

pCR Rate

NCT03894007 2021-09-23

PREDIXIIHER2

6 enrolled

Breast Neoplasms

NCT01220128 2021-05-25

INDUCT

66 enrolled 40 charts

Breast Neoplasms

NCT00625898 2020-09-10

BETH

3,509 enrolled

Breast Neoplasms

NCT02076594 2019-10-09

Low-Tox Vs Eox In Patients With Locally Advanced Unresectable Or Metastatic Gastric Cancer

171 enrolled

Stomach Neoplasms

NCT02358863 2018-09-06

mEGA

Phase NA Terminated

13 enrolled 6 charts

Esophageal Neoplasms, Stomach Neoplasms

NCT00954512 2018-08-24

Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004)

Phase 1/2 Terminated

15 enrolled 11 charts

Tumor-Agnostic

Neoplasms

NCT01690325 2018-08-13

Imaging for Response Assessment of Neoadjuvant Chemotherapy in Primary Breast Cancer (GALADON)

21 enrolled

Breast Neoplasms

NCT01830270 2018-07-26

IPEC-GC

30 enrolled

Stomach Neoplasms

NCT00096304 2018-04-10

Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate Cancer

Phase 1 Terminated

36 enrolled

Genitourinary

Prostatic Neoplasms

NCT00176488 2017-03-23

Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer

31 enrolled 6 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00912444 2016-11-22

NATT

102 enrolled

Breast Neoplasms

NCT00066807 2016-10-28

PERCHE

29 enrolled 6 charts

Breast Neoplasms

NCT01123473 2016-10-12

Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer

29 enrolled

Stomach Neoplasms

NCT00003852 2016-06-23

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors

45 enrolled

GenitourinaryGynecologic

Testicular Germ Cell Tumor, Ovarian Neoplasms, Testicular Neoplasms

NCT00130936 2016-02-15

Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates

Phase 1/2 Terminated

50 enrolled

Esophageal Neoplasms, Neoplasms, Stomach Neoplasms

NCT01697072 2016-02-09

RILOMET-1

609 enrolled

Stomach Neoplasms

NCT01985841 2015-10-08

Bevacizumab in Combination With Chemotherapy in the Neo-adjuvant Setting for HER2 (-) Breast Cancer

34 enrolled

Breast Neoplasms

NCT01167738 2015-04-24

PACT-17

60 enrolled

Pancreatic Neoplasms

NCT00053911 2014-12-16

Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer

Breast Neoplasms

NCT00756470 2014-11-17

Phase II Neoadjuvant in Inflammatory Breast Cancer

15 enrolled 10 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00198172 2014-06-03

Phase II Study of Cisplatin Plus Epirubicin Salvage Chemo in Refractory Germ Cell Tumors

37 enrolled

Neoplasms, Germ Cell and Embryonal

NCT01301040 2013-08-30

Early Cardiac Toxicity of Adjuvant CT in Elderly BC.

2 enrolled

Breast Neoplasms, Cardiotoxicity

NCT00431795 2013-02-13

Randomized Phase II Study of Epirubicin vs Caelyx in Pretreated Metastatic Breast Cancer

100 enrolled

Breast Neoplasms

NCT00824785 2012-12-11

REAL3

574 enrolled

Oesophago-gastric Cancer

NCT00193024 2011-05-03

Epirubicin and Docetaxel in the Treatment of Patients With Metastatic Breast Cancer

90 enrolled

Breast Neoplasms

NCT00162812 2008-07-18

TOP

338 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00162695 2005-09-13

Rhabdomyosarcoma and Malignant Soft Tissue Tumours of Childhood